SILIMARIN SILIMARIN HEPTOCAM HEPTOCAM HEPTOCAM SILIRIN SILIRIN SILCHOL SILLIVER SILLIVER SILLIVER HEPAMYRIN HEPAR HEPTOSIL HEPTOSIL LIPROTEC LIPROTEC HEPASIL HEPASIL SILYNORD YRIN SILIFOS SILIFOS SARIM SARIM HEPTOGEN HEPTOGEN LYMARIN SILMAR ALMIVIR ALMIVIR SILYMAX SILYMAX SYM XANOVIT XTRA EQUADIN EQUADIN SYMAC SYMAC HEPTO-C

Dose: 200 mg
Single Dose: 200 (200)
Frequency: 12 hourly
Route: PO
Instructions:

Dose: 20 to 40 mg/kg
Single Dose: 30 (30)
Frequency: 12 hourly
Route: Oral
Instructions:

belongs to Chromanones. It belongs to Cholagogues pharmacological group.

Silymarin is contraindicated in conditions like Hepatic encephalopathy,Primary biliary cirrhosis,Hypersensitivity to any component of product.

The signs and symptoms that are produced after the acute overdosage of Silymarin include Diarrhea.The symptomatic adverse reactions produced by Silymarin are more or less tolerable and if they become severe, they can be treated symptomatically, these include Weakness, Headache, Joint pain, Stomach upset.

Silymarin is primarily indicated in conditions like Hepatitis, Hepatitis A infection, Jaundice, and can also be given in adjunctive therapy as an alternative drug of choice in Cirrhosis.

No data regarding the interactions of Silymarin was found.

Drug should not be given to Paediatrics, and Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tabs, caps, syrups Store in a well closed container, at room temperature, . Protect from Moisture and Heat.

Should not be used by pregnant or breastfeeding women. People with a history of hormone-related cancers, including breast and uterine cancer and prostate cancer, should not take Silymarin. Should be use with caution in children.